Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$199.35 - $236.0 $8,173 - $9,676
41 New
41 $9,000
Q1 2024

May 03, 2024

BUY
$209.01 - $232.56 $1,881 - $2,093
9 Added 6.38%
150 $32,000
Q4 2023

Jan 26, 2024

SELL
$197.69 - $227.29 $86,588 - $99,553
-438 Reduced 75.65%
141 $32,000
Q3 2023

Oct 11, 2023

BUY
$201.05 - $221.7 $4,825 - $5,320
24 Added 4.32%
579 $116,000
Q1 2023

Apr 25, 2023

SELL
$213.32 - $257.83 $42,664 - $51,566
-200 Reduced 26.49%
555 $127,000
Q2 2022

Jul 22, 2022

SELL
$213.86 - $277.87 $30,154 - $39,179
-141 Reduced 15.74%
755 $176,000
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $1,299 - $1,490
-5 Reduced 0.55%
896 $236,000
Q4 2021

Feb 09, 2022

BUY
$271.6 - $314.21 $28,789 - $33,306
106 Added 13.33%
901 $283,000
Q3 2021

Nov 09, 2021

BUY
$274.82 - $308.34 $274 - $308
1 Added 0.13%
795 $222,000
Q2 2021

Jul 08, 2021

SELL
$251.87 - $278.14 $415,333 - $458,652
-1,649 Reduced 67.5%
794 $220,000
Q1 2021

Jun 17, 2021

SELL
$204.88 - $255.03 $16,595 - $20,657
-81 Reduced 3.21%
2,443 $649,000
Q4 2020

May 19, 2021

BUY
$186.91 - $214.42 $306,532 - $351,648
1,640 Added 185.52%
2,524 $208,000
Q2 2020

Sep 07, 2021

BUY
$113.31 - $182.44 $29,800 - $47,981
263 Added 42.35%
884 $143,000
Q4 2019

Sep 07, 2021

SELL
$163.48 - $173.61 $17,492 - $18,576
-107 Reduced 14.7%
621 $105,000
Q3 2019

Sep 07, 2021

BUY
$159.77 - $178.1 $50,966 - $56,813
319 Added 78.0%
728 $120,000
Q2 2019

Sep 07, 2021

SELL
$144.16 - $172.9 $14,560 - $17,462
-101 Reduced 19.8%
409 $70,000
Q1 2019

Sep 07, 2021

BUY
$123.7 - $156.3 $7,422 - $9,378
60 Added 13.33%
510 $78,000
Q4 2018

Sep 07, 2021

SELL
$120.82 - $174.09 $15,827 - $22,805
-131 Reduced 22.55%
450 $56,000
Q3 2018

Sep 07, 2021

BUY
$167.67 - $188.27 $36,552 - $41,042
218 Added 60.06%
581 $100,000
Q4 2017

Sep 07, 2021

BUY
$147.99 - $163.95 $2,663 - $2,951
18 Added 5.22%
363 $57,000
Q3 2017

Sep 07, 2021

SELL
$149.47 - $160.56 $2,242 - $2,408
-15 Reduced 4.17%
345 $52,000
Q2 2017

Sep 07, 2021

SELL
N/A
-1 Reduced 0.28%
360 $55,000
Q1 2017

Sep 07, 2021

SELL
N/A
-138 Reduced 27.66%
361 $51,000
Q3 2016

Sep 07, 2021

BUY
N/A
139 Added 38.61%
499 $68,000
Q1 2016

Sep 07, 2021

BUY
N/A
360
360 $42,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $22.1B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.